[Consensus document for the detection and management of chronic kidney disease]

Endocrinol Nutr. 2014 Nov;61(9):e25-43. doi: 10.1016/j.endonu.2014.06.003. Epub 2014 Aug 27.
[Article in Spanish]

Abstract

Chronic kidney disease (CKD) is an important global health problem, involving to 10% of the Spanish population, promoting high morbidity and mortality for the patient and an elevate consumption of the total health resources for the National Health System. This is a summary of an executive consensus document of ten scientific societies involved in the care of the renal patient, that actualizes the consensus document published in 2007. The central extended document can be consulted in the web page of each society. The aspects included in the document are: Concept, epidemiology and risk factors for CKD. Diagnostic criteria, evaluation and stages of CKD, albuminuria and glomerular filtration rate estimation. Progression factors for renal damage. Patient remission criteria. Follow-up and objectives of each speciality control. Nephrotoxicity prevention. Cardio-vascular damage detection. Diet, life-style and treatment attitudes: hypertension, dyslipidaemia, hyperglycemia, smoking, obesity, hyperuricemia, anemia, mineral and bone disorders. Multidisciplinary management for Primary Care, other specialities and Nephrology. Integrated management of CKD patient in haemodialysis, peritoneal dialysis and renal transplant patients. Management of the uremic patient in palliative care. We hope that this document may be of help for the multidisciplinary management of CKD patients by summarizing the most updated recommendations.

Keywords: Albuminuria; Chronic kidney disease; Chronic kidney disease detection; Chronic kidney disease stages; Cociente albúmina/creatinina en orina; Consenso; Consensus document; Detección de enfermedad rena crónica; Enfermedad renal crónica; Estadificación de enfermedad renal crónica; Filtrado glomerular; Glomerular filtration rate; Proteinuria; Urinary albumin/creatinin ratio.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Cardiovascular Agents / therapeutic use
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control
  • Combined Modality Therapy
  • Comorbidity
  • Diabetic Nephropathies / diagnosis
  • Diabetic Nephropathies / epidemiology
  • Diabetic Nephropathies / therapy
  • Diet
  • Disease Progression
  • Dyslipidemias / epidemiology
  • Dyslipidemias / therapy
  • Health Behavior
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Hypolipidemic Agents / therapeutic use
  • Interdisciplinary Communication
  • Kidney Function Tests
  • Kidney Transplantation
  • Obesity / epidemiology
  • Renal Insufficiency, Chronic / diagnosis*
  • Renal Insufficiency, Chronic / epidemiology
  • Renal Insufficiency, Chronic / pathology
  • Renal Insufficiency, Chronic / therapy*
  • Renal Insufficiency, Chronic / urine
  • Renal Replacement Therapy
  • Severity of Illness Index
  • Terminal Care

Substances

  • Cardiovascular Agents
  • Hypoglycemic Agents
  • Hypolipidemic Agents